Aspirin, clopidogrel and prasugrel monotherapy in patients with type 2 diabetes mellitus: a double-blind randomised controlled trial of the effects on thrombotic markers and microRNA levels

Table 5 Pairwise comparisons (with Bonferroni correction) for those miRNAs with significant differences between the three treatments on ANOVA

miR-	Aspirin vs. clopidogrel		Aspirin vs. prasugrel		Clopidogrel vs. prasugrel
miR-	Mean difference (95% CI)	p	Mean difference (95% CI)	p	Mean difference (95% CI)	p
21	0.17 (− 0.004 to 0.345)	0.058	0.177 (− 0.023 to 0.378)	0.100	0.007 (− 0.158 to 0.172)	> 0.99
24	0.165 (− 0.069 to 0.398)	0.262	0.295 (0.081 to 0.510)	0.004	0.131 (− 0.116 to 0.377)	0.586
191	0.208 (− 0.031 to 0.446)	0.108	0.272 (0.036 to 0.508)	0.019	0.064 (− 0.185 to 0.313)	> 0.99
197	0.153 (− 0.138 to 0.444)	0.596	0.311 (0.065 to 0.558)	0.009	0.158 (− 0.102 to 0.418)	0.416
223	0.146 (− 0.052 to 0.343)	0.220	0.226 (0.036 to 0.416)	0.014	0.08 (− 0.103 to 0.263)	0.852

ISSN: 1475-2840